Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M Haslbeck
Observed names:
M. Haslbeck,
Michael Haslbeck
Institution:
Institute of Diabetes Research
Observed institutions:
München Klinik Schwabing,
Institute of Diabetes Research
OpenAlex ID:
A5008763798
Lactacidosen bei Diabetikern unter Biguanidbehandlung
1977
·
P. Wittmann
, M. Haslbeck
, et al.
·
DMW - Deutsche Medizinische Wochenschrift
·
23
[Assessment of oral glucose tolerance].
1972
·
H Mehnert
, M Haslbeck
, et al.
·
PubMed
·
21
Orocaecal transit-time by the H2 method: effects of definitions of caecal entry and test meal.
1993
·
S Sarno
, L P Erasmus
, et al.
·
PubMed
·
11
Orocaecal transit, bacterial overgrowth and hydrogen production in diabetes mellitus.
1993
·
S Sarno
, L P Erasmas
, et al.
·
PubMed
·
10
[Diagnostic problems in diabetes mellitus].
1981
·
M Haslbeck
·
PubMed
·
7
[Treatment of diabetic gastroparesis].
1990
·
M Haslbeck
·
PubMed
·
6
[Parenteral administration of sugar substitutes with special reference to diabetes mellitus].
1974
·
M Haslbeck
·
PubMed
·
6
Intravenous administration of insulin lispro versus regular human insulin in patients with type 1 diabetes
2000
·
Roman Stiller
, Thomas Kothny
, et al.
·
Diabetes Research and Clinical Practice
·
2
Intrakutane Desensibilisierung bei einem Fall von Insulinallergie mit anaphylaktischem Schock
1979
·
W. Bachmann
, H. Hasche
, et al.
·
DMW - Deutsche Medizinische Wochenschrift
·
2
[Metabolic studies on glucose tolerance in healthy individuals and in subclinical diabetics].
1973
·
M Haslbeck
, H Pröls
, et al.
·
PubMed
·
2
[Diabetes mellitus and coffee].
1972
·
M Haslbeck
, H Mehnert
·
PubMed
·
2
[Studies on orocecal transit in diabetes mellitus].
1990
·
S Lautenbacher
, G Galfe
, et al.
·
PubMed
·
1
[The importance of bulk materials in enteral, formulated nutrition].
1986
·
P Rupp
, M Haslbeck
·
PubMed
·
1
[Emergency situations in diabetes mellitus].
1983
·
M Haslbeck
·
PubMed
·
1
[New aspects of therapy with oral antidiabetic agents].
1979
·
M Haslbeck
·
PubMed
·
1
[Effect on carbohydrate metabolism of a new saluretic, etozolin].
1979
·
M Haslbeck
, R Renner
, et al.
·
PubMed
·
1
[Course, therapy and diagnostic problems in diabetics with lactacidosis after biguanide treatment].
1978
·
M Haslbeck
, P Wittmann
, et al.
·
PubMed
·
1
[Studies on the effect of various sulfonylureas during adrenergic blockade of the insulin secretion in man].
1971
·
M Haslbeck
, K Brauch
, et al.
·
PubMed
·
1
[Norm limits of glucose tolerance].
1969
·
H Mehnert
, M Haslbeck
·
PubMed
·
1
[Blood glycogen determination in various diseases, in newborn infants, in the puerperium and pregnancy in relation to gestational age].
1968
·
M Haslbeck
, B Muck
, et al.
·
PubMed
·
1
[www.diabetes-erkennen.de. Diabetes screening 2001 Munich initiative].
2001
·
M Haslbeck
·
PubMed
[Diabetes therapy in advanced age. Managing specific problems].
1999
·
M Haslbeck
·
PubMed
[Oral diabetes therapy: when, what, how long?].
1980
·
M Haslbeck
·
PubMed
[Effect of dichloracetate on elevated blood lactate levels in biguanide treated diabetics].
1978
·
E Standl
, H U Janka
, et al.
·
PubMed
[Diagnostic relevance of 3-hour blood glucose value and serum insulin concentration in the oral glucose tolerance test].
1975
·
M Haslbeck
, H Pröls
, et al.
·
PubMed
Show more works
View as search
Works count:
31
Citation count:
101
H-index:
6
I10-index:
4
Year
Topic
Type